US4579852082
US4579852082
Integra LifeSciences Holdings C
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.05B EUR | 1.4B EUR | 733.05M EUR | 967.36M EUR |
Enterprise Value | 2.82B EUR | 3.23B EUR | 2.54B EUR | 2.77B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 5.19x | -- | -- | -- |
Price to Sales | 0.63x | 0.85x | 0.45x | 0.77x |
Price to Book | 1x | 1.34x | 0.7x | 0.93x |
EV/Revenue | 1.71x | 1.96x | 1.54x | 2.21x |
EV/EBITDA | 8.9x | 13.18x | 11.61x | 17.29x |
Price to FCF (P/FCF) | 11.07x | 120.42x | -- | -- |
EV/FCF | 29.86x | 278.57x | -- | -- |
FCF Yield | 9.03% | 0.83% | -1.38% | -0.52% |